Surrey, United Kingdom

Manuchehr Porssa


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manuchehr Porssa: Innovator in Biocompatible Compositions

Introduction

Manuchehr Porssa is a notable inventor based in Surrey, GB. He has made significant contributions to the field of biocompatible materials, particularly through his innovative patent that addresses the challenges associated with heparin activity in medical applications.

Latest Patents

Porssa holds a patent for biocompatible compositions, which involves a polymer formed from a combination of zwitterionic, cationic, and hydrophobic monomers. This polymer can be cross-linked and coated onto surfaces from a liquid composition. The unique aspect of his invention is the ability to enhance heparin activity over extended periods compared to commercially available heparinized surfaces. Additionally, the polymers can scavenge heparin from treated blood, providing a safer alternative to potentially toxic heparin inhibitors.

Career Highlights

Manuchehr Porssa is associated with Biocompatibles Limited, where he has been instrumental in advancing research and development in biocompatible materials. His work has implications for various medical applications, particularly in improving the efficacy and safety of heparin-related treatments.

Collaborations

Porssa has collaborated with notable colleagues, including Paul Matthew McNeillis and Richard Neil Templar Freeman. These collaborations have contributed to the development and refinement of his innovative biocompatible compositions.

Conclusion

Manuchehr Porssa's contributions to the field of biocompatible materials highlight his role as an innovator in medical technology. His patent for enhanced heparin activity represents a significant advancement in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…